Multi-block PLS discriminant analysis for the joint analysis of metabolomic and epidemiological data.

Discrimination Epidemiology Metabolomics Multi-block Multiblock PLS discriminant analysis

Journal

Metabolomics : Official journal of the Metabolomic Society
ISSN: 1573-3890
Titre abrégé: Metabolomics
Pays: United States
ID NLM: 101274889

Informations de publication

Date de publication:
03 10 2019
Historique:
received: 11 06 2019
accepted: 25 09 2019
entrez: 5 10 2019
pubmed: 5 10 2019
medline: 2 6 2020
Statut: epublish

Résumé

Metabolomics is a powerful phenotyping tool in nutrition and health research, generating complex data that need dedicated treatments to enrich knowledge of biological systems. In particular, to investigate relations between environmental factors, phenotypes and metabolism, discriminant statistical analyses are generally performed separately on metabolomic datasets, complemented by associations with metadata. Another relevant strategy is to simultaneously analyse thematic data blocks by a multi-block partial least squares discriminant analysis (MBPLSDA) allowing determining the importance of variables and blocks in discriminating groups of subjects, taking into account data structure. The present objective was to develop a full open-source standalone tool, allowing all steps of MBPLSDA for the joint analysis of metabolomic and epidemiological data. This tool was based on the mbpls function of the ade4 R package, enriched with functionalities, including some dedicated to discriminant analysis. Provided indicators help to determine the optimal number of components, to check the MBPLSDA model validity, and to evaluate the variability of its parameters and predictions. To illustrate the potential of this tool, MBPLSDA was applied to a real case study involving metabolomics, nutritional and clinical data from a human cohort. The availability of different functionalities in a single R package allowed optimizing parameters for an efficient joint analysis of metabolomics and epidemiological data to obtain new insights into multidimensional phenotypes. In particular, we highlighted the impact of filtering the metabolomic variables beforehand, and the relevance of a MBPLSDA approach in comparison to a standard PLS discriminant analysis method.

Identifiants

pubmed: 31583480
doi: 10.1007/s11306-019-1598-y
pii: 10.1007/s11306-019-1598-y
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

134

Références

BMC Bioinformatics. 2008 Nov 28;9:504
pubmed: 19040729
J Proteome Res. 2017 Jun 2;16(6):2262-2272
pubmed: 28440083
Rejuvenation Res. 2007 Sep;10(3):377-86
pubmed: 17708689
Bioinformatics. 2015 May 1;31(9):1493-5
pubmed: 25527831
Brief Bioinform. 2006 Jun;7(2):151-8
pubmed: 16772265
PLoS Comput Biol. 2017 Nov 3;13(11):e1005752
pubmed: 29099853
Curr Drug Metab. 2006 Jun;7(5):525-39
pubmed: 16787160
Curr Opin Chem Biol. 2013 Oct;17(5):841-6
pubmed: 23849548
Anal Chim Acta. 2015 Jun 16;879:10-23
pubmed: 26002472
OMICS. 2014 Nov;18(11):682-95
pubmed: 25387159

Auteurs

Marion Brandolini-Bunlon (M)

Université Clermont Auvergne, INRA, UNH, Plateforme d'Exploration du Métabolisme, MetaboHUB Clermont, 63000, Clermont-Ferrand, France. marion.brandolini-bunlon@inra.fr.

Mélanie Pétéra (M)

Université Clermont Auvergne, INRA, UNH, Plateforme d'Exploration du Métabolisme, MetaboHUB Clermont, 63000, Clermont-Ferrand, France.

Pierrette Gaudreau (P)

Centre de Recherche du Centre hospitalier de l'Université de Montréal, Montréal, Canada.
Département de médecine, Université de Montréal, Montréal, Canada.

Blandine Comte (B)

Université Clermont Auvergne, INRA, UNH, 63000, Clermont-Ferrand, France.

Stéphanie Bougeard (S)

Anses, BP53, Technopole Saint Brieuc Armor, 22440, Ploufragan, France.

Estelle Pujos-Guillot (E)

Université Clermont Auvergne, INRA, UNH, Plateforme d'Exploration du Métabolisme, MetaboHUB Clermont, 63000, Clermont-Ferrand, France.
Université Clermont Auvergne, INRA, UNH, 63000, Clermont-Ferrand, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH